Module 12 · Clinical Conditions · Chapters 28–31

Clinical
Conditions

Theory becomes meaningful through application. This module maps the most common clinical presentations — fatigue, digestive conditions, hormonal imbalance, and weight loss resistance — through the lens of every system covered in this manual: what the pattern looks like, what testing reveals, and the precise sequence of intervention.

Chapters 28–31 · Part VI Est. reading: 60–75 min Core clinical reference

Digestive complaints are now so common that most people consider them normal. Bloating after meals — normal. Alternating constipation and diarrhoea — just stress. Needing to know where every toilet is — that's just how some people are. Fatigue that doesn't resolve with rest — must be age. Weight that won't shift despite apparent effort — a willpower problem. Hormonal symptoms dismissed as "part of getting older."

None of it is normal. None of it is inevitable. And none of it is a mystery when you look properly. The four presentations in this module — fatigue, digestive dysfunction, hormonal imbalance, and weight loss resistance — have identifiable causes, testable patterns, and systematic resolution pathways. This module provides the clinical map for each.

◆ · ◆
Condition 1 of 4

Fatigue & Energy — The Mitochondrial Framework

Fatigue is the great non-specific symptom — it accompanies virtually every chronic condition, and conventional medicine rarely investigates it thoroughly. Thyroid normal? Here's some antidepressants. Iron fine? Must be stress. Sleep study clear? Try exercising more. What is almost never assessed is mitochondrial function — cellular energy production at its most fundamental level. When cells cannot produce adequate ATP, every system downstream suffers. The question "are your mitochondria producing enough energy?" should be asked first, not last.

Assessment — Recognising Mitochondrial Dysfunction

Cardinal symptom cluster
High suspicion when two or more of these are present

Persistent fatigue not relieved by rest — the defining feature. This is not tiredness that resolves with sleep. It is a fatigue that persists regardless of rest duration and quality.

Post-exertional malaise (PEM) — feeling significantly worse 24–72 hours after physical or cognitive exertion that would previously have been manageable. Normal exercise should be energising. Consistent depletion after activity signals mitochondria cannot meet increased demand.

Exercise intolerance — inability to sustain previous activity levels, disproportionate breathlessness or muscle fatigue relative to effort.

Cognitive fatigue and brain fog — the brain consumes 20% of total energy production despite being 2% of body weight. Mitochondrial dysfunction hits the brain hard. Difficulty concentrating, word-finding difficulties, and memory problems in the context of physical fatigue suggest cellular energy insufficiency.

Cold intolerance — generating body heat is energy-intensive. People with mitochondrial dysfunction feel cold when others are comfortable because they cannot generate adequate thermogenic ATP.

Mitochondrial dysfunction rarely occurs in isolation. Toxins, chronic infections, hormonal imbalances, blood sugar instability, and chronic inflammation all cause mitochondrial damage. Addressing mitochondrial support while ignoring what is causing the damage produces temporary and incomplete results.

What testing reveals in fatigue presentations
OAT — Primary Assessment
  • Krebs cycle intermediates (citrate, succinate, fumarate, malate) — elevated at specific points indicates enzymatic blockages at those steps
  • Elevated pyruvate/lactate ratio — glucose being shunted to anaerobic pathway instead of mitochondrial processing
  • Elevated suberate and adipate — carnitine insufficiency, fatty acid transport failure
  • Elevated HMG — CoQ10 deficiency, electron transport chain bottleneck
  • Pyroglutamic acid elevation — glutathione depletion, oxidative stress overwhelming antioxidant capacity
Blood Chemistry
  • RBC magnesium — required for Mg-ATP complex; standard serum magnesium misses intracellular deficiency
  • Ferritin — below 70 ng/mL impairs iron-sulphur cluster assembly in the electron transport chain
  • Free T3/Reverse T3 ratio — thyroid drives mitochondrial biogenesis; poor conversion produces energy impairment
  • Fasting insulin and HOMA-IR — insulin resistance creates cellular glucose starvation despite blood sugar availability
  • Inflammatory markers — chronic inflammation diverts cellular resources from ATP production to immune response
DUTCH
  • Flattened or inverted cortisol — HPA axis dysfunction is both a cause and consequence of mitochondrial impairment
  • Low DHEA relative to cortisol — depleted stress resilience buffer, ongoing catabolic state
  • Neurotransmitter metabolites — low dopamine (HVA) and serotonin (5-HIAA) consistent with chronic fatigue neurochemistry
GI-MAP
  • Endotoxin-producing dysbiosis — LPS from gram-negative bacterial overgrowth directly impairs mitochondrial membrane function
  • Pathogen burden — chronic immune activation from infections (H. pylori, parasites) is enormously energy-consuming
  • Low beneficial bacteria — butyrate producers support colonocyte mitochondria directly
  • SIBO indicators — impaired nutrient absorption depletes mitochondrial cofactors

Protocol Tiers by Severity

Tier 1 — Foundation (Mild Dysfunction or Prevention)
Ongoing maintenance
Supplements
  • CoQ10 (ubiquinol) 100–200mg daily with fat — most common bottleneck; essential for anyone on statins
  • Magnesium glycinate or malate 300–400mg daily
  • Methylated B-complex — all eight B vitamins as active forms
  • Alpha-lipoic acid 300mg daily — cofactor for pyruvate and alpha-ketoglutarate dehydrogenase, also recycles glutathione
Lifestyle foundations
  • Morning outdoor light — circadian entrainment regulates mitochondrial biogenesis timing
  • Sleep 7–9 hours — glymphatic clearance of damaged mitochondrial components occurs exclusively during sleep
  • Gentle movement only — walking and low-intensity activity until capacity is established
  • Blood sugar stabilisation — glucose dysregulation creates cellular energy paradox (high blood sugar, cellular starvation)
Retest OAT at 3–4 months to assess Krebs cycle normalisation and oxidative stress improvement. Do not expect daily improvement — mitochondrial recovery is measured in weeks to months, not days.
Tier 2 — Moderate Dysfunction
3–6 months, then reassess

Everything in Tier 1 plus increased CoQ10 to 200–300mg, acetyl-L-carnitine 1,000mg daily (fatty acid transport into mitochondria, also crosses blood-brain barrier for cognitive support), PQQ 10–20mg daily (uniquely stimulates mitochondrial biogenesis — the only known supplement that increases mitochondrial number, not just function), and NAD+ precursor (NR or NMN 250mg daily — NAD+ declines with age and is essential for electron transport chain function).

Key distinction PQQ is the only supplement that creates new mitochondria. All others support existing mitochondrial function. Include PQQ when the deficit is likely in mitochondrial number, not just efficiency — particularly in post-viral presentations, post-chemotherapy fatigue, and significantly advanced age-related decline.
Tier 3 — Significant Dysfunction
6–12 months · Practitioner guidance essential

Everything in Tier 2 plus CoQ10 increased to 400–600mg, acetyl-L-carnitine to 2,000mg daily, D-ribose 5g three times daily (provides raw ATP substrate — particularly useful for post-exertional malaise, reduces recovery time from exertion), creatine 5g daily (ATP phosphate buffer — restores ATP faster than synthesis alone), and glutathione support: NAC 1,200mg plus liposomal glutathione 250–500mg daily.

Important Tier 3 requires concurrent root cause investigation and resolution. Supporting mitochondria at this intensity while toxin burden, chronic infection, or severe hormonal dysfunction remains unaddressed produces only partial recovery. The investigation runs in parallel with the support protocol.

Post-Exertional Malaise — The Most Critical Clinical Consideration

Post-exertional malaise requires different management from other fatigue presentations. PEM indicates that energy demands are exceeding mitochondrial production capacity, and attempting to "push through" causes further mitochondrial damage. This is not deconditioning. Exercise in PEM-positive clients worsens the condition rather than improving it.

PEM management — do not push through

Priority supplements: D-ribose 5g three times daily (ATP substrate replenishment), creatine 5g daily (ATP buffer), full Tier 3 mitochondrial support. Strict pacing — stay well below the exertional threshold that triggers symptoms, often as low as 60% of maximum heart rate in severe cases.

Movement protocol: No exercise that triggers post-exertional worsening. Very gentle walking only. Gradually test boundaries as mitochondrial support takes effect over weeks. Heart rate monitoring is essential — identify the individual threshold and stay below it. As capacity improves objectively (tracked by HRV and symptom scoring), gradually expand activity range.

Extended timelines: Post-viral fatigue (including long COVID presentations) typically requires 12+ months of protocol. Recovery is possible but requires patience, pacing, and willingness to accept that previous training approaches are temporarily contraindicated.

◆ · ◆
Condition 2 of 4

Digestive Conditions — Root Causes, Not Symptom Labels

IBS is a diagnosis of exclusion — it describes a symptom pattern in the absence of identifiable "organic" pathology. What it does not do is identify the cause. In practice, behind virtually every IBS diagnosis there are identifiable, testable, addressable root causes. The label is a description of what is being observed. The investigation finds out why.

IBS — The Root Cause Patterns

Pattern 1 — Stress-Driven Gut Dysfunction
Most common pattern

The pattern most frequently seen in busy professionals: chronic sympathetic dominance directly impairing digestive function through multiple physiological mechanisms. This is not psychosomatic — it is measurable physiology. Cortisol reduces gastric acid secretion and digestive enzyme output. Blood flow diverts from digestive organs to muscles. The migrating motor complex — the wave-like contractions that sweep bacteria and debris through the small intestine — is inhibited by sympathetic activation, allowing bacterial overgrowth. Gut permeability increases. Secretory IgA production decreases.

These clients eat healthy food. They exercise. They "do everything right." But they eat while stressed, on the run, or not at all. Their nervous systems are in chronic fight-or-flight. No supplement overcomes a nervous system actively preventing digestion.

Testing reveals
  • DUTCH: Flat or dysregulated cortisol pattern, depleted DHEA
  • GI-MAP: Low secretory IgA (direct cortisol effect), dysbiosis, possibly SIBO indicators
  • Blood chemistry: Elevated hs-CRP, low ferritin and B12 from malabsorption
Intervention sequence
  • Phase 0: Nervous system regulation first — breathing protocols, parasympathetic activation before meals, HRV training
  • Then gut healing protocol per Module 11
  • Stress management is not optional — it is the prerequisite
Pattern 2 — Unidentified Pathogen Burden
Frequently missed by conventional testing

Parasites, H. pylori, and atypical bacterial overgrowths account for a significant proportion of chronic IBS presentations that fail to respond to standard gut health approaches. Standard NHS stool cultures miss most of these — they do not grow on culture media and require DNA-based quantitative PCR detection. Blastocystis hominis, Dientamoeba fragilis, and Cryptosporidium are routinely present in symptomatic clients and routinely missed by conventional testing.

Testing reveals
  • GI-MAP: Confirmed pathogen (H. pylori with virulence factors, parasite species, opportunistic overgrowths)
  • OAT: HPHPA elevation (Clostridia neurotoxic metabolites), arabinose (Candida), bacterial metabolite patterns
  • Blood chemistry: Low B12, low iron (H. pylori suppresses absorption), elevated inflammation
Intervention sequence
  • Targeted antimicrobial protocol per identified pathogen
  • Biofilm disruption before and concurrent with antimicrobials
  • Retest at 8–12 weeks — do not assume eradication
  • Second treatment round frequently needed for parasites

SIBO — Recognition, Testing, and Treatment Sequence

Small Intestinal Bacterial Overgrowth
A consequence, not a root cause — address both simultaneously

Recognition: Severe bloating within 30–60 minutes of eating (the characteristic timing — large intestinal fermentation occurs hours later). Distension that worsens throughout the day. Abdominal pain. Altered bowel habits — diarrhoea in hydrogen-dominant SIBO; constipation in methane-dominant SIBO (IMO). Nutrient malabsorption particularly B12, iron, and fat-soluble vitamins.

Why it occurs: SIBO is always a consequence of something that has impaired the mechanisms normally preventing bacterial overgrowth in the small intestine: impaired migrating motor complex (from chronic stress, post-viral damage, or medications), low stomach acid allowing bacteria to survive passage, structural issues (adhesions, diverticula), or immune deficiency. Without addressing the underlying cause, SIBO returns after treatment consistently.

Testing: Breath testing (lactulose or glucose substrate) measures hydrogen and methane gas production. GI-MAP stool analysis reveals the downstream microbiome state and markers of gut function. Blood chemistry reveals nutrient depletion consequences.

Treatment sequence — critical points: Multi-strain probiotics worsen SIBO — do not introduce until the antimicrobial phase is substantially complete. Saccharomyces boulardii is safe throughout (a yeast, not bacteria). Low-FODMAP diet during antimicrobial phase reduces fermentable substrate. Prokinetic support (ginger, prokinetic herbs, or prescription prokinetics) must accompany treatment to address the underlying motility issue — without this, SIBO recurs. Retest after treatment — do not assume clearance.

The Stress-Gut Connection — Why It Always Matters

The cortisol-gut cascade is the most consistently missed factor in chronic digestive presentations. When cortisol is chronically elevated or dysregulated, the effects on digestion are systemic: reduced gastric acid (leading to SIBO risk and malabsorption), reduced enzyme output, reduced gut blood flow, increased permeability, suppressed secretory IgA, disrupted migrating motor complex, and altered microbiome composition toward opportunistic organisms.

"A high-achieving woman who 'does everything right' with diet can still have severe IBS. Her nervous system is preventing her gut from functioning normally, regardless of what she eats."

Stephen Duncan FDN-P MSc

The vicious cycle: stress impairs gut function → gut dysfunction causes inflammation and nutrient depletion → inflammation and depletion impair stress resilience → reduced resilience increases stress response → greater stress further impairs gut function. Breaking this cycle requires addressing both ends simultaneously — calming the nervous system and healing the gut. Doing one without the other consistently produces incomplete results. The three pillars of gut restoration in stress-driven presentations are Calm (parasympathetic activation), Nourish (targeted gut support), and Rebuild (microbiome and barrier restoration).

◆ · ◆
Condition 3 of 4

Hormonal Conditions — Reading the Network, Not the Isolated Marker

Most people think hormones are just about reproduction — oestrogen for women, testosterone for men. But hormones regulate virtually every process in the body: energy production, metabolism, immune function, mood, sleep, stress response, tissue repair, inflammation control. When hormones are balanced, you feel energetic, maintain stable weight, sleep well, handle stress, think clearly, and have stable mood. When they are imbalanced, everything suffers. And hormonal imbalances rarely show up on standard medical testing until they are severe — leaving most people in the gap between "clinically abnormal" and "optimal function."

The critical insight that conventional endocrinology consistently misses: hormones do not operate independently. They are an interconnected network with constant communication, feedback loops, and interdependencies. Fixing one hormone without understanding the others it regulates and is regulated by produces incomplete results. You cannot fix thyroid without addressing cortisol. You cannot balance oestrogen without addressing the gut's estrobolome. You cannot optimise testosterone without addressing insulin resistance and aromatase activity.

The Five Clinical Patterns

The Exhausted High-Achiever
HPA Axis Dysfunction — Stage 2/3

High-performing professional managing multiple responsibilities, previously functioned well under stress, now cannot. Wakes up exhausted despite adequate sleep, depends on multiple coffees to function, crashes mid-afternoon, anxiety and brain fog, weight gain despite careful diet, cannot recover from exercise. The hallmark: they used to handle this level of demand. Something changed.

Testing reveals
  • DUTCH: Elevated morning cortisol (Stage 1/2) or flat pattern (Stage 3), depleted DHEA, often reversed CAR
  • Blood chemistry: Low Free T3 with normal TSH (cortisol suppressing conversion), blood sugar instability
  • OAT: Depleted neurotransmitter metabolites, mitochondrial dysfunction from chronic stress burden
Intervention sequence
  • HPA axis support first — adaptogenic herbs, sleep prioritisation, nervous system protocols
  • Do not add HIIT or intense exercise — this person cannot recover from it yet
  • Blood sugar stabilisation (protein at every meal, no skipping)
  • Thyroid support after HPA axis is stabilised, not before
The Oestrogen Dominant Woman
Oestrogen:Progesterone Imbalance + Estrobolome Dysfunction

Heavy, painful periods. Severe PMS — mood swings, breast tenderness, bloating in the days before menstruation. Weight gain in hips and thighs. Fibrocystic breasts. Often constipated. History of fibroids or endometriosis. May be on oral contraceptives that mask the symptom pattern without addressing the underlying cause.

Testing reveals
  • DUTCH: Normal or elevated oestrogen with low progesterone producing relative dominance; 4-OH oestrogen metabolite elevation (genotoxic pathway); poor 2-methylation capacity
  • GI-MAP: Elevated beta-glucuronidase (bacterial enzyme recirculating conjugated oestrogen in the colon)
  • Blood chemistry: Elevated hs-CRP (oestrogen-inflammation connection)
Intervention sequence
  • Gut microbiome correction to reduce beta-glucuronidase — this alone often meaningfully reduces oestrogen dominance
  • Methylation support (methylated B vitamins) — supports 2-OH oestrogen pathway
  • DIM or calcium-D-glucarate — support oestrogen metabolism toward protective metabolites
  • Progesterone support (herbs or bioidentical based on DUTCH findings)
Perimenopausal Chaos
Hormonal Volatility — Not Simple Decline

Women in their 40s experiencing irregular cycles, hot flushes, night sweats, mood swings, anxiety, insomnia, weight gain, and brain fog. Often told "it's just menopause" and offered antidepressants or HRT without testing. The clinical reality is more complex: perimenopause involves wild hormonal volatility before decline — not simple linear reduction. Oestrogen fluctuates unpredictably (some days spiking, triggering anxiety and breast tenderness; other days crashing, triggering hot flushes and mood drops). Progesterone declines earlier than oestrogen, creating temporary oestrogen dominance. Standard single-point testing misses these fluctuations entirely.

Testing reveals
  • DUTCH: The volatility pattern — multiple collections across the cycle reveal fluctuation amplitude and direction
  • Blood chemistry: Thyroid status (hypothyroid mimics menopause), adrenal reserve (DHEA-S)
  • OAT: Mitochondrial status (energy symptoms often have cellular component)
Intervention sequence
  • HPA axis stability first — cortisol volatility amplifies hormonal volatility
  • Thyroid optimisation — low Free T3 worsens all perimenopausal symptoms
  • Progesterone support through transition (prevents relative oestrogen dominance)
  • HRT consideration based on metabolite pattern — 2-OH predominance suggests safer candidate than 4-OH predominance
The Low-Testosterone Man
Multi-Factor — Often Addressable Without TRT

Mid-30s to 50s: declining energy, difficulty building muscle despite training, increasing belly fat, reduced libido, poor recovery, mood changes. Standard testing checks total testosterone once, declares "low-normal for your age," and offers nothing — or goes immediately to testosterone replacement therapy without investigating why levels dropped.

Testing reveals
  • Blood chemistry: Total testosterone plus SHBG (elevated SHBG reduces free fraction), oestradiol (aromatase converting testosterone to oestrogen in visceral fat)
  • DUTCH: Cortisol pattern (chronic stress depletes testosterone through pregnenolone steal), 5-alpha reductase activity
  • Blood chemistry: Fasting insulin and HOMA-IR — insulin resistance drives aromatase and reduces testosterone
Intervention sequence
  • Insulin resistance correction — often produces significant testosterone recovery without any hormone intervention
  • HPA axis support — reduces pregnenolone steal
  • Body composition improvement — visceral fat reduction decreases aromatase activity
  • Zinc and vitamin D optimisation — both required for testosterone synthesis
  • TRT consideration after addressing root causes — works better with fewer side effects when these are corrected first
The Thyroid Disconnect
Conversion and Utilisation Failure — Not Production Failure

Classic hypothyroid symptom picture — fatigue, weight gain, hair loss, cold intolerance, constipation, dry skin, brain fog — with a "normal" TSH of 2–3 mIU/L. Conventional testing stops at TSH. The clinical reality: TSH measures pituitary output only, not what is reaching the cells. The thyroid produces T4 (inactive); conversion to active T3 occurs in the liver, gut, and peripheral tissues. This conversion is blocked by chronically elevated cortisol (favouring reverse T3), systemic inflammation, gut dysbiosis (which performs 20% of T4-to-T3 conversion), and multiple nutrient deficiencies (selenium, iodine, zinc, iron).

Testing reveals
  • Full thyroid panel: TSH, Free T4, Free T3, Reverse T3, anti-TPO, anti-thyroglobulin
  • Low Free T3 with normal TSH — conversion problem, not production problem
  • Elevated Reverse T3 — inactive form blocking thyroid receptors (cortisol or inflammatory driver)
  • Positive antibodies — autoimmune Hashimoto's requiring immune modulation alongside thyroid support
Intervention sequence
  • HPA axis normalisation — reduces cortisol-driven Reverse T3 elevation
  • Gut repair — restores gut contribution to T4 conversion
  • Nutrient repletion: selenium (200mcg daily), iodine (from food), zinc, iron to optimal ferritin
  • Inflammation reduction — systemic inflammation directly impairs conversion
  • Thyroid medication (T3-containing or T3 alone) if conversion is irreparably impaired after addressing root causes

Gut–Hormone Interdependence

The gut affects hormones through mechanisms most endocrinologists never address. The estrobolome — the collection of gut bacteria that produce beta-glucuronidase — directly determines circulating oestrogen levels by controlling oestrogen reabsorption from the colon. Gut dysbiosis with excessive beta-glucuronidase activity produces oestrogen dominance independent of oestrogen production. This is why oestrogen dominance patterns on DUTCH resolve when gut microbiome is corrected — without any direct hormone intervention. Approximately 20% of T4-to-T3 thyroid conversion occurs in the gut through intestinal sulfatase enzymes. Gut inflammation systemically disrupts the entire hormonal network through cytokine interference with the hypothalamic-pituitary signalling cascade. You cannot achieve lasting hormonal balance without addressing the gut.

What DUTCH Testing Reveals That Standard Testing Cannot

Single-point blood hormone tests provide one data point at one moment in a dynamic 24-hour cycle. Cortisol measured at 9am tells you what cortisol was doing at 9am — nothing about evening levels, morning surge adequacy, or whether the pattern is appropriate to the rhythm. Oestrogen measured once gives a level but no information about how it is being metabolised — the 2-OH vs 4-OH vs 16-OH metabolite ratios that determine cancer risk are completely invisible to standard blood testing. The oestrogen level might be normal while the metabolite pattern is dangerous.

DUTCH provides: the complete diurnal cortisol curve across four time points (revealing pattern, not just level), oestrogen metabolite ratios (revealing metabolism, not just production), the cortisol-to-DHEA resilience ratio, androgen metabolism (DHT conversion, aromatase activity), melatonin production (6-OH-melatonin sulphate from the first morning void), neurotransmitter metabolites (serotonin, dopamine, noradrenaline patterns), and nutritional markers (B12 and B6 functional status, methylation capacity, glutathione conjugation capacity). This is the difference between a snapshot and a clinical map.

◆ · ◆
Condition 4 of 4

Weight Loss Resistance — The Systems Approach

Weight that does not respond to reduced calories and increased exercise is one of the most common clinical presentations and one of the most consistently mishandled. The standard model — calories in, calories out — fails to account for the physiological variables that determine how many calories are burned, stored, or accessible. When the system is dysregulated, the mathematics of energy balance produce different outcomes in different people. Weight loss resistance is rarely about insufficient effort. It is almost always about unaddressed physiological drivers.

The Hidden Drivers — What Testing Reveals

Insulin Resistance

The most common and most overlooked driver. When cells resist insulin signalling, the pancreas produces progressively more insulin to maintain blood sugar control. Chronically elevated insulin locks fat in adipose tissue — insulin is the primary fat-storage signal. You cannot access fat stores in a high-insulin environment regardless of caloric deficit. Testing: fasting insulin, HOMA-IR (often abnormal 10–15 years before glucose elevates). Optimal fasting insulin is below 5–7 µIU/mL; most weight-resistant clients are at 15–25+.

Cortisol Dysregulation

Chronic cortisol elevation promotes visceral fat accumulation specifically — not generalised weight gain, but abdominal adiposity in the pattern that most elevates cardiovascular and metabolic risk. Cortisol triggers gluconeogenesis (glucose production from muscle protein), impairs insulin sensitivity, promotes fat storage, and elevates appetite through ghrelin stimulation. Someone training hard with high stress may be gaining muscle, gaining fat, and losing neither — their cortisol is counteracting every effort. Testing: full DUTCH cortisol pattern including CAR and metabolites.

Thyroid Insufficiency

Thyroid hormone is the metabolic thermostat — it determines how fast cells burn fuel. Even subclinical hypothyroidism (TSH above 2.5 but technically "normal") produces meaningful metabolic rate reduction. Weight gain of 4–7kg is common before TSH reaches the diagnostic threshold. The conversion problem makes this worse: standard T4 replacement does not help if the problem is conversion failure. Testing: full thyroid panel including Free T3 and Reverse T3.

Gut Dysfunction and Endotoxaemia

Gut dysbiosis with gram-negative bacterial overgrowth produces lipopolysaccharide (LPS) endotoxin. When gut permeability is elevated, LPS enters circulation — metabolic endotoxaemia. LPS triggers systemic inflammation, impairs insulin signalling directly, and promotes visceral fat accumulation through inflammatory cytokine activation of fat storage pathways. The gut microbiome also influences caloric extraction from food, appetite hormone production (ghrelin and GLP-1), and short-chain fatty acid production affecting metabolic rate.

Sleep Deprivation

One week of sleeping 5 hours nightly produces insulin resistance equivalent to gaining 20–30 pounds — metabolically, not physically, but the metabolic consequence is identical. Leptin (satiety hormone) drops 15–20%, ghrelin (hunger hormone) rises 15–30%, endocannabinoids activating food reward increase, and resting metabolic rate decreases. Sleep-deprived people consume 200–500 additional calories daily, predominantly at night, predominantly from high-carbohydrate, high-fat foods. No dietary intervention compensates for chronic sleep deprivation at a metabolic level.

Oestrogen Dysregulation

Oestrogen dominance (relative to progesterone) promotes water retention and fat accumulation in the hip-thigh pattern. Low oestrogen in menopause shifts fat distribution to visceral accumulation, simultaneously increasing cardiovascular and metabolic risk. Elevated oestrogen in men (from aromatase activity in visceral fat) creates a self-reinforcing cycle: visceral fat → aromatase → higher oestrogen → more visceral fat. Testing reveals the direction and mechanism, making intervention specific rather than generic.

Mitochondrial Insufficiency

When mitochondria cannot efficiently convert fuel to ATP, cells signal energy insufficiency and downregulate metabolic rate. The paradox: high blood sugar (plenty of fuel available) combined with cellular energy starvation (cannot process the fuel efficiently). This pattern — common in post-viral fatigue, significant thyroid insufficiency, and CoQ10 depletion — produces weight gain despite apparent caloric deficit because resting metabolic rate has dropped to match available ATP production capacity.

Chronic Inflammation

Inflammatory cytokines (TNF-α, IL-6) directly block insulin receptor signalling, promote adipogenesis (fat cell formation), and impair lipolysis (fat cell breakdown). The source of inflammation drives the clinical approach: food sensitivities, gut infections, autoimmune activation, environmental toxins, or visceral fat itself (which is metabolically active and pro-inflammatory). Treating inflammation without identifying its source produces temporary benefit only.

Treatment Sequence — Systems Before Calories

Why caloric restriction alone fails weight loss resistance

When insulin is chronically elevated, fat stores are locked regardless of caloric deficit. When cortisol is chronically elevated, muscle is catabolised for glucose while fat accumulates. When thyroid conversion is impaired, resting metabolic rate drops to compensate for energy production inefficiency. When sleep is inadequate, appetite hormones override any dietary discipline the following day.

The systems must be corrected before caloric restriction becomes effective. This is why clients who have "tried everything" have not failed — they have not yet addressed the physiological variables that determine whether caloric restriction produces the expected outcome. Once these are corrected, the body responds to appropriate dietary and exercise intervention rather than resisting it.

The treatment sequence for weight loss resistance follows the established TDG clinical hierarchy. HPA axis first — cortisol normalisation is the single most impactful intervention for visceral adiposity and insulin resistance. Blood sugar stabilisation through Metabolic Nature-appropriate eating, post-meal walking, and if indicated, targeted supplementation (berberine, chromium, magnesium). Gut restoration — addressing dysbiosis, pathogen burden, and intestinal permeability reduces metabolic endotoxaemia and restores gut hormones governing appetite and satiety. Thyroid optimisation — confirming adequate Free T3 and addressing conversion failure if present. Sleep restoration — without this, all dietary and exercise interventions operate in a metabolically impaired environment. Only then does structured nutrition and progressive exercise produce reliable, sustained results.

Module 12 — Key Takeaways

What this module establishes

  • Post-exertional malaise is the diagnostic signal for severe mitochondrial dysfunction — it requires strict pacing, not "pushing through." Exercise in PEM-positive clients causes further mitochondrial damage, not adaptation
  • PQQ is the only supplement known to stimulate mitochondrial biogenesis — all other mitochondrial supplements support existing function. Include PQQ specifically when mitochondrial number, not just efficiency, is the deficit
  • IBS is a symptom label, not a diagnosis. Behind most IBS presentations are identifiable, testable, addressable root causes: stress-driven autonomic dysfunction, unidentified pathogen burden, SIBO, or intestinal permeability
  • SIBO is a consequence, not a root cause — the migrating motor complex dysfunction, low stomach acid, or structural issue that allowed it must be addressed alongside antimicrobial treatment, or SIBO returns reliably
  • Multi-strain Lactobacillus/Bifidobacterium probiotics worsen SIBO by feeding the overgrowth. Sequencing matters: antimicrobial phase substantially complete before introducing broad probiotic support
  • The stress-gut cycle requires addressing both ends simultaneously — nervous system regulation is a clinical prerequisite for gut healing, not an optional addition to the supplement protocol
  • Hormones operate as an interconnected network. Oestrogen dominance may be driven by gut dysbiosis (beta-glucuronidase elevation) rather than excess oestrogen production. Low testosterone may be driven by insulin resistance and aromatase activity rather than primary gonadal failure
  • DUTCH testing reveals hormone metabolism (metabolite ratios), rhythm (diurnal pattern), and conversion capacity — information completely invisible to standard single-point blood hormone testing
  • The Thyroid Disconnect presents with classic hypothyroid symptoms and normal TSH because the problem is T4-to-T3 conversion failure, not T4 production failure — driven by cortisol, inflammation, gut dysfunction, and nutrient deficiencies
  • Weight loss resistance is almost always physiological, not motivational. Insulin resistance, cortisol dysregulation, thyroid insufficiency, gut-derived metabolic endotoxaemia, sleep deprivation, and mitochondrial impairment all produce weight accumulation that caloric restriction cannot overcome until they are corrected
← Module 11: The Intervention Toolkit
Module 12 of 13
↑ All Modules
Module 13: Building Your Protocol →